Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock
[at noodls] – NEW HAVEN, Conn., Feb. 20, 2013 (GLOBE NEWSWIRE) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that it has commenced an underwritten public offering of $125 million of its common stock. … more
View todays social media effects on ACHN
View the latest stocks trending across Twitter. Click to view dashboard